CD70 is a potential target biomarker in peripheral T-cell lymphomas

Affiliations

• ¹ Department of Translational Molecular Pathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
• ² CRISPR Therapeutics, Zug, Switzerland.
• ³ Department of Lymphoma and Myeloma, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
• ⁴ Department of Pathology and Laboratory Medicine, University of Miami/Jackson Memorial Hospital, Miami, FL, USA.
• ⁵ Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
• ⁶ Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.